Stay updated on Immuno-therapy Study of BMS-986156 in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immuno-therapy Study of BMS-986156 in Solid Cancers Clinical Trial page.

Latest updates to the Immuno-therapy Study of BMS-986156 in Solid Cancers Clinical Trial page
- ChecktodayChange DetectedThe study record no longer lists a 2015 U.S. NIH grant/contract identifier among its study identifiers. The site revision indicator also updates from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record for the BMS-986156 trial is available, with details on its completed Phase 1/2a study in advanced solid tumors, including participant eligibility, treatment arms, locations, and reported outcomes.SummaryDifference65%

- Check21 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2; the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page continues to display a 403 Forbidden error. The footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Immuno-therapy Study of BMS-986156 in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-therapy Study of BMS-986156 in Solid Cancers Clinical Trial page.